Related references
Note: Only part of the references are listed.Comprehensive Evaluation of Non-invasive Prenatal Screening to Detect Fetal Copy Number Variations
Jing Wang et al.
FRONTIERS IN GENETICS (2021)
Application of chromosomal microarray in fetuses with increased nuchal translucency
Xin-Rong Zhao et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2020)
Detection rates and residual risk for a postnatal diagnosis of an atypical chromosome aberration following combined first-trimester screening
Erik Iwarsson et al.
PRENATAL DIAGNOSIS (2020)
Chromosomal microarray as primary diagnostic genomic tool for pregnancies at increased risk within a population-based combined first-trimester screening program
I. Vogel et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2018)
Prenatal diagnostic testing and atypical chromosome abnormalities following combined first-trimester screening: implications for contingent models of non-invasive prenatal testing
A. Lindquist et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2018)
Population-based impact of noninvasive prenatal screening on screening and diagnostic testing for fetal aneuploidy
Lisa Hui et al.
GENETICS IN MEDICINE (2017)
Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis
M. M. Gil et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2017)
Risk of fetal loss associated with invasive testing following combined first-trimester screening for Down syndrome: a national cohort of 147 987 singleton pregnancies
C. B. Wulff et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2016)
Chromosomal microarray in fetuses with increased nuchal translucency
I. C. B. Lund et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2015)
Uptake of noninvasive prenatal testing at a large academic referral center
Sebastian Larion et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2014)
Chromosome Abnormalities Detected by Current Prenatal Screening and Noninvasive Prenatal Testing
Mary E. Norton et al.
OBSTETRICS AND GYNECOLOGY (2014)
Potential diagnostic consequences of applying non-invasive prenatal testing: population-based study from a country with existing first-trimester screening
O. B. Petersen et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2014)
Repeat measurements of nuchal translucency at 11-14 weeks of gestation: when do we need them?
L. J. Salomon et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2013)
Screening for trisomy 18 by maternal age, fetal nuchal translucency, free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A
K. O. Kagan et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2008)
First-trimester screening for chromosomal abnormalities
KH Nicolaides
SEMINARS IN PERINATOLOGY (2005)
A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free β-hCG and PAPP-A
K Spencer et al.
PRENATAL DIAGNOSIS (2002)
Share Paper
